OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot study.

Kent Are JamtøyErling TronvikDaniel Fossum BratbakJoan CrespiLars Jacob StovnerIrina AschehougWenche Moe Thorstensen

Published in: Acta oto-laryngologica (2021)

Injection of BTA toward the SPG using the MultiGuide® in patients with CRSwNP appears to be safe but with a potential for moderately disabling side effects. The study indicates a beneficial effect on nasal obstruction.

Keyphrases

chronic rhinosinusitis
ultrasound guided
risk assessment
depressive symptoms
climate change